November 14, 2019:
The acronym EVALI is officially implemented for “e-cigarette, or vaping, product use associated lung injury.”
2,172 EVALI cases were reported to the CDC.
EVALI cases were reported by 29 states, D.C., the U.S. Virgin Islands, and Puerto Rico.
42 EVALI-related deaths were confirmed in 24 states and D.C.
For the first time, the CDC detected a potential chemical of concern in EVALI patient samples.
Vitamin E acetate was found in all samples from 29 EVALI patients across 10 different states. The samples were taken from the EVALI patients’ lungs.
Tetrahydrocannabinol (THC) was identified in 82% of samples taken from the population of 29 EVALI patients.
Nicotine was identified in 62% of samples taken from the population of 29 EVALI patients.
CDC checked for other chemicals that might be found in e-cigarette products. No other chemical of concern was detected in the samples tested from the population of 29 EVALI patients.